Drug Discovery & Development [1] |
Diabetes Drug Gains Approval for Treatment of Obesity [2]
New York Times The Food and Drug Administration approved a Novo Nordisk diabetes drug as a treatment for obesity, the first injectable drug approved for weight loss. The drug, liraglutide, will be marketed under the brand name Saxenda for obese adults and for … FDA approves weight-management drug Saxenda [3]FDA.gov FDA approves Novo Nordisk's injection for obesity [4]CNBC Novo Nordisk kick-starts its obesity franchise with a long-awaited FDA nod [5]FierceBiotech CBS News [6] –Skin and Allergy News Digital Network [7] –Minneapolis Star Tribune [8] all 118 news articles » [9] |
More details can be found at www.diabeteshowto.com [10]